Offers a comprehensive range of services for developing tissue-engineered constructs, cell-based therapies and biologics
Stemmatters is a leading contract development and manufacturing organization (CDMO). Its domain of expertise lies within Regenerative Medicine, for which we offer a comprehensive range of services for developing tissue-engineered constructs, cell-based therapies and biologics. As vertically integrated company, Stemmatters operates seamlessly across all stages of product development, from exploratory R&D to cGMP production and batch release. Stemmatters offers an innovative biomaterial platform to support formulation of advanced therapies for multiple indications, enabling our partners to deliver cutting-edge solutions to unmet medical needs.
Rui A. Sousa – CEO